Rehabilitation Research and Development Service Scientific Merit Review Board; Federal Register Notice of Meeting, 6572 [2024-02002]
Download as PDF
6572
Federal Register / Vol. 89, No. 22 / Thursday, February 1, 2024 / Notices
dialing the phone number (1–833–558–
0712) and entering the meeting number/
access code (2761 198 6545).
Written comments from members of
the public must be sent to Tiffin RossShepard, Designated Federal Officer,
HSRD, Department of Veterans Affairs
(14RDH), 810 Vermont Avenue NW,
Washington, DC 20420, or to
Tiffin.Ross-Shepard@va.gov at least five
days before the meeting. The public
comments will be shared with the Board
members. The public may not attend the
closed portion of the meeting, as
disclosure of research information could
significantly obstruct implementation of
proposed agency action regarding the
research proposals. As provided by
Public Law 92–463 subsection 10(d),
and amended by Public Law 94–409,
closing the committee meeting is in
accordance with title 5 U.S.C. 552b(c)(6)
and (9)(B).
Dated: January 29, 2024.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
[FR Doc. 2024–02006 Filed 1–31–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF VETERANS
AFFAIRS
Rehabilitation Research and
Development Service Scientific Merit
Review Board; Federal Register Notice
of Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
The Department of Veterans Affairs
(VA) gives notice under the Federal
Advisory Committee Act, 5 U.S.C. ch.
10, that a meeting of the Rehabilitation
Research and Development Service
VerDate Sep<11>2014
17:12 Jan 31, 2024
Jkt 262001
(RR&D) Scientific Merit Review Board
(hereinafter, ‘‘the Board’’) will be held
on Wednesday, March 6, 2024, via
Webex from 1–1:30 p.m. EST. The
meeting will be partially closed to the
public, with an open portion from 1–
1:10. The closed portion, from 1:10–1:30
p.m., will be used for discussion,
examination of and reference to the
research applications and scientific
review. Discussions will involve
reference to staff and consultant
critiques of research proposals.
Discussions will also cover the scientific
merit of each proposal and the
qualifications of personnel conducting
the studies, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Additionally, premature disclosure of
research information could significantly
obstruct implementation of proposed
agency action regarding the research
proposals. As provided by Public Law
92–463 subsection 10(d), and amended
by Public Law 94–409, closing the
committee meeting is in accordance
with 5 U.S.C. 552b(c)(6) and (9)(B).
The objective of the Board is to
provide for the fair and equitable
selection of the most meritorious
research projects for support by VA
research funds and to offer advice for
research program officials on program
priorities and policies. The ultimate
objective of the Board is to ensure that
the VA RR&D program promotes
functional independence and improves
the quality of life for impaired and
disabled Veterans.
Board members will advise the
Director of RR&D and the Chief
Research and Development Officer on
the scientific and technical merit,
PO 00000
Frm 00074
Fmt 4703
Sfmt 9990
mission relevance and protection of
human and animal subjects of the
proposals submitted to RR&D. The
Board does not consider grants,
contracts or other forms of extramural
research.
Members of the public may attend the
open portion of the meeting via WebEx,
from 1–1:10 p.m., in listen-only mode,
as the time-limited open agenda does
not allow for public comment
presentations. To attend the open
portion of the meeting, the public may
dial the Webex phone number (1–833–
558–0712), then enter the meeting
access code (2764 419 8398).
Written comments from members of
the public should be mailed to Kristy
Benton-Grover, Designated Federal
Officer, RR&D, Department of Veterans
Affairs (14RDR), 810 Vermont Avenue
NW, Washington, DC 20420, or to
Kristy.Benton-Grover@va.gov at least
five days before the meeting. The public
comments will be shared with the Board
members. The public may not attend the
closed portion of the meeting as
disclosure of research information could
significantly obstruct implementation of
proposed agency action regarding the
research proposals. As provided by
Public Law 92–463 subsection 10(d),
and amended by Public Law 94–409,
closing the committee meeting is in
accordance with title 5 U.S.C. 552b(c)(6)
and (9)(B).
Dated: January 29, 2024.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
[FR Doc. 2024–02002 Filed 1–31–24; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\01FEN1.SGM
01FEN1
Agencies
[Federal Register Volume 89, Number 22 (Thursday, February 1, 2024)]
[Notices]
[Page 6572]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02002]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Rehabilitation Research and Development Service Scientific Merit
Review Board; Federal Register Notice of Meeting
The Department of Veterans Affairs (VA) gives notice under the
Federal Advisory Committee Act, 5 U.S.C. ch. 10, that a meeting of the
Rehabilitation Research and Development Service (RR&D) Scientific Merit
Review Board (hereinafter, ``the Board'') will be held on Wednesday,
March 6, 2024, via Webex from 1-1:30 p.m. EST. The meeting will be
partially closed to the public, with an open portion from 1-1:10. The
closed portion, from 1:10-1:30 p.m., will be used for discussion,
examination of and reference to the research applications and
scientific review. Discussions will involve reference to staff and
consultant critiques of research proposals. Discussions will also cover
the scientific merit of each proposal and the qualifications of
personnel conducting the studies, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Additionally, premature disclosure of research information could
significantly obstruct implementation of proposed agency action
regarding the research proposals. As provided by Public Law 92-463
subsection 10(d), and amended by Public Law 94-409, closing the
committee meeting is in accordance with 5 U.S.C. 552b(c)(6) and (9)(B).
The objective of the Board is to provide for the fair and equitable
selection of the most meritorious research projects for support by VA
research funds and to offer advice for research program officials on
program priorities and policies. The ultimate objective of the Board is
to ensure that the VA RR&D program promotes functional independence and
improves the quality of life for impaired and disabled Veterans.
Board members will advise the Director of RR&D and the Chief
Research and Development Officer on the scientific and technical merit,
mission relevance and protection of human and animal subjects of the
proposals submitted to RR&D. The Board does not consider grants,
contracts or other forms of extramural research.
Members of the public may attend the open portion of the meeting
via WebEx, from 1-1:10 p.m., in listen-only mode, as the time-limited
open agenda does not allow for public comment presentations. To attend
the open portion of the meeting, the public may dial the Webex phone
number (1-833-558-0712), then enter the meeting access code (2764 419
8398).
Written comments from members of the public should be mailed to
Kristy Benton-Grover, Designated Federal Officer, RR&D, Department of
Veterans Affairs (14RDR), 810 Vermont Avenue NW, Washington, DC 20420,
or to [email protected] at least five days before the
meeting. The public comments will be shared with the Board members. The
public may not attend the closed portion of the meeting as disclosure
of research information could significantly obstruct implementation of
proposed agency action regarding the research proposals. As provided by
Public Law 92-463 subsection 10(d), and amended by Public Law 94-409,
closing the committee meeting is in accordance with title 5 U.S.C.
552b(c)(6) and (9)(B).
Dated: January 29, 2024.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-02002 Filed 1-31-24; 8:45 am]
BILLING CODE 8320-01-P